| 前收市價 | 12.95 |
| 開市 | 13.52 |
| 買盤 | 13.98 x 500 |
| 賣出價 | 14.03 x 500 |
| 今日波幅 | 13.45 - 14.52 |
| 52 週波幅 | 10.92 - 59.99 |
| 成交量 | |
| 平均成交量 | 1,028,553 |
| 市值 | 841.494M |
| Beta 值 (5 年，每月) | 0.85 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -9.05 |
| 業績公佈日 | 2024年4月25日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 24.31 |
ZacksSage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Data from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
ZacksSage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Sage Therapeutics (SAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investor's Business DailySage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
Sage Therapeutics said Wednesday its Parkinson's treatment failed in a midstage study, and Sage stock collapsed to a record low.
